相关实验视频

Updated: Jan 8, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

全国婴儿罗塔病毒疫苗接种前后患乳病的风险:基于人口的研究

Maria Östman¹, Lars C Stene², German Tapia²

¹Faculty of Medicine, University of Oslo, Oslo, Norway.

The Journal of pediatrics

|December 12, 2025

概括

这项研究发现,轮状病毒疫苗接种与儿童早期患乳病的风险之间没有联系. 罗塔病毒疫苗似乎不会增加患乳病的可能性.

科学领域:

儿科胃肠病学儿科胃肠病学
疫苗学疫苗学疫苗学
流行病学流行病学

背景情况:

轮状病毒疫苗接种和腹腔疾病风险之间的关系是正在进行的科学辩论的主题.
了解潜在的联系对于公共卫生建议和家长指导至关重要.

研究的目的:

调查轮状病毒疫苗接种与乳病发病率在大量儿科队列中的关联.
为了确定轮状病毒疫苗的引入是否改变了乳病诊断的趋势.

主要方法:

在挪威,一项基于登记的全国性队列研究包括超过74万名儿童.
用中断时间序列分析和比较风险评估来评估疫苗的影响.
与出生,患者和免疫登记处的数据链接提供了全面的随访.

主要成果:

在引入轮状病毒疫苗后,没有观察到乳病发病率趋势的显著变化.
在接种疫苗和未接种疫苗的儿童中,患乳病的风险比没有显著差异.
敏感性分析和替代案例定义产生了一致的结果,没有显示任何关联.

结论:

这项研究提供了强有力的证据,证明轮状病毒疫苗接种与早期患乳病的风险增加无关.
这些发现支持罗塔病毒疫苗在患乳病发展方面的安全性.

关键词:

这是自身免疫力.患有乳性疾病的患者.孩子们的孩子们的孩子们的孩子们.传染病是一种传染性疾病.儿科儿科儿科轮状病毒疫苗轮状病毒疫苗疫苗疫苗疫苗疫苗

更多相关视频

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

相关概念视频

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Vaccinations

Vaccinations